Russian scientists are developing a neutron accelerator for the point of killing cancer cells

Boron neutron capture cancer therapy allows you to point out a malignant tumor cells - such

cells are determined by the system according to the presence of a stable boron isotope - boron-10. The solution of the latter is injected into human blood and serves as a marker of affected cells.

Now researchers are working to create an accelerator neutron source that will accurately deliver boron to the affected areas.

"New drugs must effectively deliver boroninto tumor cells and, bypassing healthy tissues, create in them the maximum concentration of this substance. Specialists are exploring the possibilities of three different candidates for the role of boron carrier - albumin protein molecules, aptamers (short nucleic acid sequences) and bacteriophages. In the next three years, we hope to create a drug that is associated with glioblastoma with much greater efficiency than the existing foreign analogues "

Vladimir Richter, Head of the Laboratory of Biotechnology, ICBFM SB RAS

Earlier, scientists from the University of Tokyo createdNext-generation biopharmaceuticals are nanomachines that deliver cancer drugs to hard-to-reach areas, such as the human brain.